http://www.bing.com/news/search?q=depomed&form=QBNT&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=depomed&form=QBNT&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.fool.com%2finvesting%2f2018%2f02%2f28%2fheres-why-depomed-inc-fell-as-much-as-138-today.aspx&c=6163487100225843805&mkt=en-usShares of specialty pharmaceuticals provider Depomed (DEPO +0.00%) fell nearly 14% today after the company released fourth-quarter and full-year 2017 results after Tuesday's closing bell. The company ...Wed, 28 Feb 2018 12:40:00 GMTThe Motley Foolhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.yahoo.com%2fnews%2fhorizon-pharma-raises-offer-depomed-115435343.html&c=12731171409564702501&mkt=en-usAdd Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Ireland-based Horizon Pharma Plc (HZNP.O) raised its offer to buy Depomed Inc (DEPO.O) to $33 (£21.2) per share, ...Tue, 21 Jul 2015 04:54:00 GMTYahoohttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.fool.com%2finvesting%2f2017%2f12%2f06%2fwhy-depomed-incs-shares-are-rallying-10-today.aspx&c=11480980143520478467&mkt=en-usWhile Depomed can't turn back the clock on acquiring Nucynta, it announced today that Collegium Pharmaceutical has agreed to license it from them. Collegium Pharmaceutical will pay Depomed $10 million ...Wed, 06 Dec 2017 09:05:00 GMTThe Motley Foolhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2frebel-depomed-investor-adds-former-j-j-abbott-execs-to-its-proposed-board-slate&c=6693212818099420360&mkt=en-usRebel Depomed investor Starboard Value wants a special meeting as soon as possible--and to get its wish, it’s taking matters into its own hands. The hedge fund, which owns about 9.9% of the California ...Tue, 26 Jul 2016 04:59:00 GMTFiercePharmahttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2ftroubled-depomed-sells-off-nucynta-axes-40-workforce-to-pare-down-costs&c=16945154811962113501&mkt=en-usDepomed is selling off the franchise that was once the center of its growth hopes, and plenty of the company's employees are leaving with it. Less than three years after shelling out $1.05 billion to ...Tue, 05 Dec 2017 04:20:00 GMTFiercePharmahttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.fiercebiotech.com%2fbiotech%2fcovidien-and-depomed-announce-license-agreement&c=4815424921696319725&mkt=en-usST. LOUIS & MENLO PARK, Calif., Nov 24, 2008 (BUSINESS WIRE) -- Covidien and Depomed, today announced that Covidien has licensed worldwide rights from Depomed to utilize Depomed's AcuForm(TM) gastric ...Mon, 24 Nov 2008 03:42:00 GMTFierceBiotechhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fchicago.suntimes.com%2f2015%2f9%2f8%2f18398385%2fhorizon-takes-hostile-depomed-bid-directly-to-shareholders&c=2605240138249588579&mkt=en-usWhy are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...Mon, 07 Sep 2015 16:59:00 GMTChicago Sun-Timeshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.yahoo.com%2fnews%2fexclusive-drugmaker-depomed-prepares-explore-214658633.html&c=18298683077900751289&mkt=en-us(Reuters) - Drug maker Depomed Inc (DEPO.O) is preparing to put itself up for sale, following calls from activist investor Starboard Value LP to explore such a move, just a year after it fought off a ...Thu, 15 Sep 2016 14:46:00 GMTYahoohttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.mercurynews.com%2f2015%2f09%2f07%2fhorizon-pushes-hostile-depomed-bid-with-shareholder-offer%2f&c=7508794321409408365&mkt=en-usHorizon Pharma is pushing ahead with its hostile, $2.4-billion bid to buy Depomed by starting an offer to exchange a portion of its stock for shares of the rival drugmaker. Horizon Pharma makes the ...Tue, 08 Sep 2015 10:55:00 GMTMercury Newshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.cbsnews.com%2fnews%2fdepomed-ceo-pelzel-discusses-seradas-cold-flush-and-placebo-issues%2f&c=17571306705525455408&mkt=en-usDepomed announced earlier this week that its investigational non-hormonal therapeutic option for the treatment of menopausal hot flashes, Serada (formerly known as DM-5689), failed to meet its primary ...Fri, 16 Oct 2009 11:31:00 GMTCBS Newshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.seattletimes.com%2fbusiness%2fdepomed-gives-starboard-chance-for-meeting-to-replace-board%2f&c=8781904291478882750&mkt=en-usDepomed is taking another step to avoid the pain of a protracted fight with activist investor Starboard Value over control of the drugmaker. The pharmaceutical company said Monday that its board has ...Sun, 24 Apr 2016 23:07:00 GMTSeattle Timeshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a33c133242648c894f6b9e60c835601&url=https%3a%2f%2fwww.chron.com%2fbusiness%2ffool%2farticle%2fWhat-Caused-DepoMed-s-Shares-to-Skyrocket-20-9-7392872.php&c=3998458260229630319&mkt=en-usWhat: After activist investor Starboard Value LP took a nearly 10% stake in DepoMed , the company's shares soared 20.9% last month, according to data from S&P Global Market Intelligence. So what: ...Wed, 04 May 2016 04:40:00 GMTHouston Chronicle